Bookmark and Share

(GWPC) Release of the FDA Cleared “HIV 1&2” Rapid Diagnostic Test

ANAHEIM, Calif., Sept. 23, 2014 /PRNewswire/ — This test can detect HIV infection if used 3 months after a risk event. A “risk event” is defined by activities that can transfer body fluids from one person to another, including blood transfusions, tattoos, or use of any shared needles.

  • An in-vitro diagnostic home-use test for HIV (HIV-1 and HIV-2) in oral fluid. This HIV test works by looking for your body’s response to fighting the HIV virus (antibodies).
    Provides results in 20 minutes, enabling patients to learn their status in a single visit and allows HIV positive patients to be connected to care immediately.
  • Flexible
    Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens. Ideal for both clinical and non-clinical settings.
  • Accurate
    Greater than 99% agreement with confirmatory Western blot.1
  • Simple
    CLIA-waived for oral fluid, fingerstick and venipuncture whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics.

Inspired by its slogan, Love Life. Live Long.”  WholeHealth is committed to building long-term relationships with the medical and healthcare professional and the patients, helping save lives.

WholeHealth Products Inc. your partner in the “Business of Science”

Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHealth Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

Headquartered in Anaheim, California, WholeHealth Products. (OTC: GWPC) is a diversified company comprised of several specialized partners focused on leveraging the power and convenience of advanced technology and the proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHealth Products’ line of more than 10 professional diagnostic tests (Strep A, H. Pylori, Influenza A, Influenza B, Influenza A&B Combo, Fecal Occult Blood, Pregnancy, Ovulation, Menopause, Mononucleosis, Cholesterol, Troponin I, Drug of Abuse Tests, and NOW HIV 1&2 for hospitals, doctors, clinics and healthcare centers, and its more than 8 retail consumer tests is proud to announce an addition to its line of rapid diagnostic tests.

Tuesday, September 23rd, 2014 Uncategorized